Provided by Tiger Trade Technology Pte. Ltd.

CRO Concept

1,624.13
+54.793.49%
Number of Gainers:2
Number of Losers:- -
Number of Flat:1
PE:- -
High:1,645.20
Open:1,585.82
Low:1,583.04
Close:1,569.34
Volume:4.43M
Turnover:828.07M
Market Cap:41.19B
Float Cap:39.47B

Loading ...

IQVIA Leans On AI And Boehringer Deal As Shares Struggle

Simply Wall St.
·
Yesterday

Gartner Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Yesterday

IQVIA Holdings Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Feb 06

Iqvia price target lowered to $240 from $280 at UBS

TIPRANKS
·
Feb 06

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 06

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EST

Reuters
·
Feb 06

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Omnicell (OMCL) and MiMedx Group (MDXG)

TIPRANKS
·
Feb 05

IQVIA Exec Says AI More Likely to Augment Client's Team but Not Replace Company

THOMSON REUTERS
·
Feb 05

IQVIA Exec Says AI Is an Opportunity Not a Challenge for Business

THOMSON REUTERS
·
Feb 05

IQVIA Exec Says Co Expects Q1 2026 Adj EPS Between $2.77 and $2.87

THOMSON REUTERS
·
Feb 05

IQVIA Exec Says Demand for AI-Driven Innovations Gaining Momentum With Clients, Especially Large Pharma - Conf Call

THOMSON REUTERS
·
Feb 05

IQVIA Exec Says Co Expects Q1 2026 Sales Between $4.05 Bln and $4.15 Bln

THOMSON REUTERS
·
Feb 05

IQVIA posts Q4 2025 revenue of USD 4.36 billion, up 10%

Reuters
·
Feb 05

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

THOMSON REUTERS
·
Feb 05

IQVIA Q4 EPS USD 2.99

THOMSON REUTERS
·
Feb 05

IQVIA Q4 Adjusted EPS USD 3.42 VS. Ibes Estimate USD 3.4

THOMSON REUTERS
·
Feb 05

IQVIA Holdings Down Over 9%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk

Dow Jones
·
Feb 04

AstraZeneca reports FDA issued CRL for BLA for subcutaneous Saphnelo

TIPRANKS
·
Feb 03

What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment?

Benzinga_recent_news
·
Feb 03

Leerink sees ‘silver lining’ in Aquestive CRL given defined path to approval

TIPRANKS
·
Feb 02